Iron Mountain Incorporated

New York Stock Exchange
Back to all articles
Bullish +65

Is Iron Mountain Stock Underperforming the Nasdaq? - inkl

AI-generated analysis

📈 IRM is trading above both its 200-day and 50-day moving averages since early February and January, respectively, indicating a sustained bullish trend.

💰 The company reported Q1 revenue of $1.9 billion, representing a 21.5% year-over-year increase following the April 30 earnings release.

📊 AFFO per share grew by 22.2% year-over-year to reach $1.43, demonstrating strong operational cash flow generation.

🚀 Shares rose more than 10% immediately after Q1 results, outperforming the Nasdaq Composite with a 53.4% gain year-to-date.

🏆 Wall Street analysts hold a consensus 'Strong Buy' rating for IRM based on its prospects in the records management sector.

🎯 The mean analyst price target is set at $131.54, implying approximately 3.4% upside from current trading levels.

🏢 Iron Mountain serves a wide range of industries including banking, healthcare, energy, and life sciences with its data management solutions.

Bullish Signals
  • IRM reported robust Q1 revenue growth of 21.5% year-over-year, reaching $1.9 billion.
  • The company achieved a significant 22.2% increase in AFFO per share to $1.43.
  • Stock performance has been strong recently, with a 53.4% gain year-to-date outpacing the Nasdaq.
  • Technical indicators show the stock trading above key moving averages since early January and February.
  • Wall Street consensus is overwhelmingly bullish with a 'Strong Buy' rating from 12 analysts.
  • The company maintains a substantial market cap of $37.9 billion, solidifying its large-cap status.
Full Analysis
Iron Mountain Incorporated (IRM), a Portsmouth, New Hampshire-based REIT specializing in records management, data solutions, and information destruction, serves diverse industries including banking, healthcare, and life sciences. With a market capitalization exceeding $37.9 billion, the company is classified as a large-cap stock, reflecting its significant influence within the specialty real estate investment trust sector. Recent performance metrics show IRM trading above its 200-day and 50-day moving averages since early February and January, respectively, confirming a bullish trend. The stock gained 18.5% over the past three months and rose 53.4% year-to-date, outperforming the Nasdaq Composite's gains during those specific periods, though it underperformed the broader index over the full 52-week span. Following a strong Q1 report released on April 30, IRM shares surged more than 10%, driven by revenue growth of 21.5% year-over-year to $1.9 billion and an Adjusted Funds From Operations (AFFO) per share increase of 22.2% to $1.43. Wall Street analysts maintain a consensus 'Strong Buy' rating with a mean price target of $131.54, suggesting potential upside from current levels despite the stock slipping slightly from its 52-week high.